Oncology & Cancer
New pill could offer hope to bowel cancer and gastrointestinal stromal tumor patients after failure of standard treatmen
Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel cancer or gastrointestinal stromal tumor following failure of existing treatments.
Nov 21, 2012
0
0